Trastuzumab Showed Improved Survival In Stage IV Breast Cancer with CNS Metastases
Majority of Invasive Bladder Cancer Patients Do Not Receive Full Recommended Care
Pertuzumab Delays Progression In HER2-Positive Breast Cancer
Sentinel Lymph Node Excision Has No Impact on Survival
Increased Breast Density Can Lead to Higher Risk
Computer Interpretation Software Does Not Improve Detection
Bone Marrow Transplant Survival Has Doubled In Young Patients
Two Studies Demonstrate Molecule Blocking Cell Damage
Interim Analysis Suggests Paclical Can Reduce Blood Levels
Hormone Therapy Can Reduce Survival In Men With Heart Problems
Zometa Can Reduce Risk Of Skeletal-Related Events
Cell Phone Radiation Does Not Raise Child’s Risk of Tumors
Clinical Trials Approved by NCI CTEP Last Month
Trending Stories
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- NIH cuts threaten U.S. edge in biomedical research: “We are giving China the opportunity of a lifetime”
Cancer research also took center stage at Senate appropriations hearing - The White House “skinny budget” document cuts NIH by nearly 40%
The cuts are consistent with the previously leaked “passback” document - Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit - Did Vinay Prasad need to mention the Nazis to make a point on the U.S. pandemic response?
